Alnylam Pharmaceuticals
ALNY
#533
Rank
$43.88 B
Marketcap
$330.87
Share price
4.68%
Change (1 day)
22.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company